Mechanistically, METTL3 promotes lactate production from pyruvate; when METTL3 is knocked down, LDHA‐mediated glycolysis is inhibited, reducing chemoresistance to 5‐FU in CRC cells [166]. This evidence concerns the gene METTL3 and colorectal carcinoma.